Frontera Health

The company's core offering is a tech-enabled platform that utilizes artificial intelligence and machine learning to support Board-Certified Behavior Analysts (BCBAs) and diagnosticians. A key feature is its "Digital Phenotyping" solution, which analyzes video of therapeutic sessions at 30 frames per second to provide objective data and track interactions, leading to more precise, data-driven care plans. This technology, combined with tools like the "Diagnosis Builder" and "Assessment Builder," significantly reduces the time spent on paperwork, enabling clinicians to create diagnostic reports and comprehensive assessments in a fraction of the traditional time. By streamlining these clinical workflows, Frontera aims to shorten waitlists and accelerate the delivery of crucial early interventions.

Frontera Health's business model is twofold: it develops and commercializes its AI-powered software for behavioral health providers and also operates its own full-service Applied Behavior Analysis (ABA) clinics. These clinics, located in rural areas of New Mexico, serve as real-world settings to test, validate, and refine its technology, ensuring the tools are effective in day-to-day clinical practice. The company launched in February 2025 with a substantial $32 million in seed funding, co-led by premier investors Lux Capital and Lightspeed Venture Partners, with participation from Bison Ventures, Menlo Ventures, and Inspired Capital.